Ipilimumab/Nivolumab Followed by Nivolumab Regimen

Preferred Label : Ipilimumab/Nivolumab Followed by Nivolumab Regimen;

NCIt synonyms : Nivolumab/Ipilimumab Followed by Nivolumab; Ipilimumab/Nivolumab Followed by Nivolumab; Yervoy/Opdivo Followed by Opdivo;

NCIt definition : A regimen consisting of ipilimumab and nivolumab followed by nivolumab that can be used for the treatment of kidney, colorectal, esophageal and esophagogastric junction, and hepatobiliary cancers, cutaneous and uveal melanoma, ampullary, appendiceal and small bowel adenocarcinoma, well-differentiated grade 3 neuroendocrine tumors (NETs), extrapulmonary poorly differentiated neuroendocrine carcinoma/large or small cell carcinoma/mixed neuroendocrine-non-neuroendocrine neoplasm, and Merkel cell carcinoma.;

NCI Metathesaurus CUI : CL1905820;

Details

Origin ID

C198666;

UMLS CUI

C5855027;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Ipilimumab [NCIt concept]
- Nivolumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients